Shionogi & Co., Ltd.

Shionogi & Co., Ltd. is a leading pharmaceutical company specializing in the research, development, and distribution of pharmaceutical products. Established in Japan in 1878, Shionogi focuses primarily on three therapeutic areas: infectious diseases, pain/CNS, and oncology. The company is known for its commitment to innovation in drug discovery, aiming to address unmet medical needs through advanced healthcare solutions. Notably, Shionogi has made significant contributions to the development of anti-infective medications, including antibiotics and antiviral treatments, positioning itself as a key player in the fight against global health challenges. In addition to pharmaceuticals, Shionogi expands its reach through ventures in healthcare services and bioinformatics. As a prominent entity in the pharmaceutical industry, Shionogi holds strategic partnerships with various global companies and research institutions, enhancing its impact on the international market. With a dedication to enhancing the quality of life, Shionogi & Co., Ltd. continues to play a crucial role in addressing critical health issues through its innovative solutions and robust product pipeline.

CEO

Dr. Isao Teshirogi Ph.D.

Employees

4,955

Website

shionogi.com